Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 12 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

3 trials in Phase 3/4

Results Transparency

13%

1 of 8 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

5(41.7%)

Phase 2

4(33.3%)

Phase 4

3(25.0%)

12Total

N/A(5)

Phase 2(4)

Phase 4(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials

NCT01400087Not ApplicableCompleted

Cap-attached Colonoscopy Versus Regular Colonoscopy for Trainees

Role: lead

NCT04710251Not ApplicableUnknown

Effectiveness of Using the Speedometer During Colonoscopy

Role: collaborator

NCT01592617Phase 2Unknown

Phase II Study of S-488410 to Treat Non-small Cell Lung Cancer

Role: collaborator

NCT00190580Phase 4Completed

Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease

Role: collaborator

NCT02054195Phase 4Completed

Training Model on Insertion Techniques for Postplacental Intra Uterine Device

Role: lead

NCT01454635Not ApplicableCompleted

Analisis of Facors Involved in Antidepressant Treatment Response of Major Depressive Disorder

Role: lead

NCT01232205Phase 2Completed

Antioxidant Supplementation in Pregnant Women

Role: lead

NCT01232192Not ApplicableUnknown

Study of Antenatal Model to Prevent Preterm Delivery

Role: lead

NCT00388856Phase 2Completed

Antioxidant Supplementation in Pregnant Women With Low Antioxidant Status

Role: lead

NCT00763633Phase 4Unknown

B6 Treatment for Nausea and Vomiting in Pregnancy

Role: lead

NCT00571831Not ApplicableCompleted

The Effect of a Blue Light Filtering IOL

Role: lead

NCT00482183Phase 2Completed

Comparison Between Pioglitazone and SES With type2 DM

Role: lead

All 12 trials loaded